Newer Migraine Drugs Reduce Headache Days With Fewer Side Effects, Study Finds
A review in Annals of Internal Medicine finds most CGRP-targeted therapies cut migraine days by about two per month. Evidence for older medications was weaker, according to researchers.
Health News is provided as a service to A and S Drugs site users by HealthDay. A and S Drugs nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.